文献速递艾滋病与性传播感染

低复杂度病毒学抑制HIV感染者年度与半年随访的随机试验

Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial.
PubMed 文献 · Clin Infect Dis · 2026-08-19

这项单中心随机非劣效试验比较了低复杂度HIV感染者年度随访与半年标准随访,主要终点为病毒学控制非劣效(预设下限-4%)。年度随访组病毒学控制率与标准组临床相当,但未达到正式非劣效阈值;年度随访与患者满意度显著提升及HIV直接成本降低相关。

要点

  • 年度随访病毒学控制率与半年随访临床相当,但未达正式非劣效阈值。
  • 年度随访组高满意度参与者比例较基线显著增加(p=0.001)。
  • 年度随访组HIV相关直接成本降低25.3%(p<0.001)。

核心结论

  • 在低复杂度HIV感染者中,年度随访病毒学结局与半年随访临床相当,但未达到正式非劣效阈值。
  • 年度随访与患者满意度显著提升及HIV直接相关成本降低相关。

研究设计与样本

  • 前瞻性、单中心、随机、非劣效临床试验,比较半年标准随访与年度随访24个月。
  • 共321例病毒学抑制且低复杂度HIV感染者随机分组(标准组162例,年度组159例)。

主要发现

  • 病毒学控制率标准组与年度组分别为86.42% vs 86.79%(ITT)和98.29% vs 97.87%(PP)。
  • 年度随访组高满意度参与者比例较基线显著增加(p=0.001)。
  • 年度随访组HIV相关直接成本降低25.3%(p<0.001)。

关键数值与推荐

  • 主要终点为非劣效性,预设下限为-4%,病毒学控制定义为病毒载量<50 copies/mL(FDA snapshot)。
  • 低复杂度依据GeSIDA「HIV Patient Stratification System」定义。

临床怎么用

  • 对低复杂度且病毒学抑制的HIV感染者,年度随访可作为半年随访的临床可行替代方案。
  • 年度随访可能提升患者满意度并降低HIV相关直接成本。

局限性

  • 非劣效性未达到正式统计学阈值,需谨慎解读临床可比性。
  • 单中心设计可能限制结果外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The increasing heterogeneity in people with HIV makes it necessary to evaluate new follow-up strategies tailored to clinical/social complexity. METHODS: Prospective, single-center, randomized, non-inferiority clinical-trial comparing two follow-up strategies - semi-annual standard care (SoC) or annual visits for 24 months- in virologically suppressed people with HIVand low-complexity profile, according to the GeSIDA "HIV Patient Stratification System". The primary endpoint was non-inferiority (prespecified lower margin: -4%) in virological control (viral load <50 copies/mL; FDA snapshot). Secondary outcomes included adherence, quality of life, satisfaction, and healthcare costs. RESULTS: Of 394 eligible candidates, 71 declined participation (48% preferring to maintain SoC) and 321 were randomized (162 SoC, 159 Annual). Participants were predominantly male (89%), MSM (78%), Spanish (63%), median age of 45 years and 13 years of HIV follow-up, without baseline differences between groups. Overall, 283 (88%) completed the study; 25 switched to long-acting therapy and 10 were lost or transferred. Virological control was similar in SoC and Annual arms: 86.42% vs 86.79% (ITT) and 98.29% vs 97.87% (PP), although non-inferiority was not statistically demonstrated. During the study, the increment from baseline in the proportion of highly satisfied participants was significant in the Annual arm (p=0.001). Reductions in HIV-related direct costs (-25.3%; p<0.001) were greater in the Annual group. CONCLUSIONS: Among people with HIV and low complexity, annual follow-up achieved virological outcomes clinically comparable to semi-annual care, despite not meeting the formal non-inferiority threshold. Annual follow-up was associated with significant increment in patient satisfaction and lower HIV direct-related costs.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Chivite I, Merino-Peñas MJ, González-Cordón A, et al. Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial. Clin Infect Dis. 2026. PMID: 42617095. doi:10.1093/cid/ciag491

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。